Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Clin Neurophysiol. 2023 Feb 16;149:1–8. doi: 10.1016/j.clinph.2023.01.021

Table 1.

Sample Description

ADHD TD difference
N 75 29 -
Age in years M (SD) 9.28 (1.34) 8.83 (1.23) p = .106
Female 29% 34% p = .785
Non-White 39% 31% p = .619
Task Accuracy M (SD) 80% (9%) 85% (7%) p = .003
Full-Scale IQ M (SD) 109 (10) 118 (11) p = .001
Average ADHD Symptom Severity M (SD) 1.42 (0.62) −0.66 (0.59) p < .001
Individual P3 Trials M (SD) 25.72 (3.52) 27.31 (1.87) p = .004
Trial-Centered P3 Trials M (SD) 20.49 (3.21) 21.66 (2.72) p = .068

Note: ADHD = attention deficit hyperactivity disorder; TD = typically developing. M = mean; SD = standard deviation. Average ADHD symptom severity was calculated as the mean severity of parent ratings of 18 ADHD symptoms on the SWAN, with a range of −3 to 3; higher scores indicate greater ADHD symptom severity. Individual P3 and Trial-Centered P3 Trials = the number of trials included in the individual P3 amplitude or trial-centered P3 variables, respectively. Difference tests were independent samples t-tests for continuous variables (age, accuracy, novel trials, IQ); and chi-square tests for categorical variables (female, non-white). Bolded p values indicate statistically significant group differences at p < .05.